1 / 56

Video Capsule Endoscopy

Video Capsule Endoscopy. Cem KALAYCI Marmara University Head, Dept. of Gastroenterology ESGAR, Istanbul 2008. Small Intestinal Capsule. Comparative Capsule Designs. VCE. PillCam (PillCam SB). (Given Imaging; Yoqneam, Israel): FDA Approval 2000. EndoCapsule (Olympus): FDA Approval 2007

ponce
Télécharger la présentation

Video Capsule Endoscopy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Video Capsule Endoscopy Cem KALAYCI Marmara University Head, Dept. of Gastroenterology ESGAR, Istanbul 2008

  2. Small Intestinal Capsule

  3. Comparative Capsule Designs

  4. VCE • PillCam (PillCam SB). (Given Imaging; Yoqneam, Israel): FDA Approval 2000. • EndoCapsule (Olympus): FDA Approval 2007 • Similar characteristics to the PillCam SB but has a CCD chip instead of a CMOS chip.

  5. Given vs Olympus • 51 patients with obscure GI bleeding • PillCam SB and the EndoCapsule 40 minutes apart in randomized order • Similar results for normal and abnormal Gastrointest Endosc 2007; 65:AB125.

  6. CAPSULE ENDOSCOPY

  7. The Diagnostic Process

  8. Technics • Two images per second • 55,000 images over eight hours. • Magnification 1:8 • Review of the video, generation of a report: 30 to 90 minutes. • Viewing: 1-25 frames per second (standard video speed).

  9. Primary Indications • Obscure gastrointestinal bleeding • Suspected Crohn's disease • Small bowel tumors

  10. Gastric Antral Vascular Ectasia (GAVE)

  11. Angioectasia in Ileum

  12. Aphthous Ulcers

  13. Crohn’s Disease: Ulcers

  14. Crohn’s Disease: Edema

  15. Crohn’s Disease: Strictures

  16. Gastrointestinal Stomal Tumors (GIST)

  17. Other Indications • NSAID injury to the small bowel • Abdominal pain (functional vs organic) • Celiac disease

  18. NSAID Ulceration

  19. NSAID Stricture/Webs

  20. Celiac Disease

  21. Additional Applications • Small bowel polyps • Rejection in small bowel transplantation • GVH diseaase after bone marrow transplantation • Surveillance of patients with hereditary polyposis syndromes.

  22. Advantages • Noninvasive • Examination of the majority of the small bowel mucosa, which is not possible with push enteroscopy • Small bowel series, enteroclysis, and intra-operative enteroscopy are capable of examining the entire length of the small bowel, they are either quite insensitive or invasive.

  23. Disadvantage • No tissue sampling or therapeutic intervention.

  24. Obscure Bleeding

  25. Obscure Bleeding(100 patients) n Pos.Study (%) • Ongoing overt bleeding 26 92 • Previous overt bleeding 31 13 • FOBT + and IDA 43 44 Pennazio et al, Gastroenterology 2004;126:643.

  26. MOST COMMON FINDINGS • Angioectasia (29 percent) • Crohn's disease (6 percent). • Diagnostic yield is highest when performed as close as possible to the bleeding episode. Pennazio et al, Gastroenterology 2004;126:643.

  27. Obscure Bleeding • Sixty-two patients underwent further examination that led to independent verification of the diagnosis in 56. • Sensitivity: 89 %, Specificity: 95 % • PPV: 97 % NPV: 83 % • Ongoing obscure bleeding (overt or occult) are the best candidates Pennazio et al, Gastroenterology 2004;126:643.

  28. Video Capsule Endoscopy vs Push Enteroscopy in the Diagnosis of Obscure GI Bleeding

  29. Yield in Obscure bleeding • A meta-analysis of 14 studies: • Capsule endoscopy: (63 percent) • Push enteroscopy (26 percent), • Barium studies (8 percent) Triester, SL et al. Am J Gastroenterol 2005; 100:2407.

  30. VCE vs SBFT • 22 patients suspected of having small bowel pathology, underwent both VCE and SBFT. • Diagnostic study: VCE: 45 % SBFT: 20 % • Finding the cause of Obscure bleeding: VCE: 31% SBFT: 5 % Costamagna, G, et al. Gastroenterology 2002;123:999.

  31. Hadithi M, et al. Am J Gastroenterol 2006:100 :1-6

  32. VCE vs DBE • Diagnosing the etiology: VCE: 80 % DBE: 60 % • A procedure/treatment was performed in 77 % of the patients with DBE • 74 % of the patients remained stable during 5 month follow up Hadithi M, et al. Am J Gastroenterol 2006:100 :1-6

  33. Crohn’s Disease

  34. Crohn’s Disease n VCE Push Entero Crohn’s 22 17 3 4 Suspected CD 21 4* 0 1 (false) *2 were false diagnosis Chong et al, Gastrointest Endosc 2005;61:255-61

  35. Crohn’s Disease • VCE detected more erosions than push entero and enteroclysis (p<0.001) • There was no difference in patients with suspected Crohn’s disease. • Capsule endoscopy had a higher yield than push enteroscopy and enteroclysis in patients with known Crohn's disease Chong et al, Gatsrointest Endosc 2005;61:255-61 Marmo, R, et al. Clin Gastroenterol Hepatol 2005; 3:772.

  36. Video Capsule Endoscopy and the Diagnosis of Suspected Crohn’s Disease

  37. VCE vs Barium in suspected Crohn’s recurrence • Studies produced complementary results • VCE: Mucosal disease in six patients with a normal SBFT • SBFT: Grade 1 mucosal disease in five patients with a normal VCE study. Buchman, AL, et al. Am J Gastroenterol 2004; 99:2171.

  38. Risk: Retention of the capsule • Clinically important retention < 1 %. • Patients with increased risk • known or suspected Crohn's disease • intermitent SB obstruction secondary to adhesions • radiation enteritis • severe motility disorders • Zenker's diverticulum. • A normal barium study or CT scan does not exclude the possibility of retention.

  39. Capsule Retention • Palpation by the surgeon of the capsule retained above a stricture may be helpful in localizing the stricture, which may have no serosal signs, thus avoiding the need for intra-operative enteroscopy. • Removal of the retained capsule by double balloon enteroscopy has also been described

  40. Patency capsule • Same size as the PillCam • Composed of lactose and barium • Contains a radiofrequency identification tag that allows it to be detected by a scanning device • Dissolves in 40 to 80 hours after ingestion.

  41. Patency capsule • To assure small bowel patency before VCE • Diagnostic test for suspected small bowel strictures that cannot be identified by standard radiographic means. • 25 percent of patients with strictures developed abdominal pain, some severe, and two patients required emergency surgery Delvaux, M, V, et al. Endoscopy. 2005; 37:801.

  42. Contraindications • Dementia • Gastroparesis (the capsule can be placed in the duodenum by endoscopy) • Esophageal stricture, swallowing disorders (eg, Zenker's diverticulum) (endoscopic placement)

  43. Contraindications • Partial or intermittent small bowel obstruction • Those who are inoperable or refuse surgery • Patients who have defibrillators or pacemakers. This is a recommendation in the package insert, but does not appear to be a significant clinical problem.

  44. Thank you.....

More Related